Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease

por Fishbane, Steven, Spinowitz, Bruce S., Wisemandle, Wayne A., Martin, Nancy E.
Publicado 2019

Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: a post hoc analysis of a randomized European-Australian Phase 3 trial

por Khullar, Vik, Cambronero, Javier, Angulo, Javier C, Wooning, Marianne, Blauwet, Mary Beth, Dorrepaal, Caroline, Martin, Nancy E
Publicado 2013

Long-term Safety of Epoetin Alfa-epbx for the Treatment of Anemia in ESKD: Pooled Analyses of Randomized and Open-label Studies

por Wish, Jay B., Rocha, Marcelo G., Martin, Nancy E., Reyes, Christian Russel D., Fishbane, Steven, Smith, Mark T., Nassar, George
Publicado 2019